NP
NovaBay Pharmaceuticals, Inc.
SEC filingOther · Emeryville, CA
Amount raised$134Msold at filing
Total offering$134M
Investors in the raise4count reported to the SEC
FiledJan 27, 2026first sale Jan 16, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael John KazleyExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.